TRPC1 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P48995 |
---|---|
Clone Names | 100507208 |
Gene ID | 7220 |
---|---|
Other Names | Short transient receptor potential channel 1, TrpC1, Transient receptor protein 1, TRP-1, TRPC1, TRP1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | TRPC1 |
---|---|
Synonyms | TRP1 |
Function | Thought to form a receptor-activated non-selective calcium permeant cation channel. Probably is operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G- protein coupled receptors. Seems to be also activated by intracellular calcium store depletion. |
Cellular Location | Membrane; Multi-pass membrane protein. |
Tissue Location | Seems to be ubiquitous. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
TRPC1 belongs to the transient receptor potential (TRP)superfamily of cation channels. TRP cation channels are involved indiverse physiologic processes, including receptor- andstore-operated Ca(2+) entry, mineral absorption, and cell death.They also function as sensors for pain, heat, cold, sound, stretch,and osmotic changes (Zhang et al., 2009 [PubMed19193631]).
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Bomben, V.C., et al. Glia 58(10):1145-1156(2010)Lu, M., et al. J. Mol. Endocrinol. 44(5):285-294(2010)Gonzalez-Cobos, J.C., et al. Front. Biosci. 15, 1023-1039 (2010) :Ingueneau, C., et al. J. Cell. Mol. Med. 13 (8B), 1620-1631 (2009) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.